ACRV Acrivon Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 12, 2026
$1,99
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$1,27minimo 52 sett.
$3,56massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$85M
P/E
-1.0
EPS
$-2.02
i tuoi badge
Intervallo 52 sett.
$1–$4
Rating Analisti
BUY
Prezzo Obiettivo
$12
P/E
-1.0
ROE
-61.0%
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
ACRV Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$1.99
Capitalizzazione di Mercato (MRQ)
$85M
P/E
-1.0
EPS
$-2.02
ROE
-61.0%
Intervallo 52 sett.
$1–$4
ACRV Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
EPS$-2.022021-12-31 → 2025-12-31
Flusso di cassa libero$-65M2022-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | ACRV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -1.0media 5 anni ≈-1.8 | ≈-1.8 | · | · | |
| P/B (MRQ) | 1.0media 5 anni ≈1.0 | ≈1.0 | 1.7 | Sottovalutato | |
| Prezzo / FCF (TTM) | -1.3media 5 anni ≈-3.6 | ≈-3.6 | · | · | |
| Prezzo / Flusso di cassa (TTM) | -1.4media 5 anni ≈-3.8 | ≈-3.8 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 0.6media 5 anni ≈1.0 | ≈1.0 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | ACRV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| ROA | -47.8%media 5 anni ≈-38.8% | ≈-38.8% | -25.2% | Debole | |
| ROE | -61.0%media 5 anni ≈-50.1% | ≈-50.1% | -50.0% | Sotto la media | |
| ROIC | -74.8% | · | -51.6% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | ACRV | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 8.0media 5 anni ≈12.1 | ≈12.1 | 5.3 | Liquidità elevata | |
| Quick Ratio | 7.6media 5 anni ≈11.8 | ≈11.8 | 2.7 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
11.3%
Prossimo report
Nov 11, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 19, 2026 | $-0.43 | $-0.51 | 15.7% |
| 31 Marzo 2026 | Mag 20, 2026 | $-0.49 | $-0.54 | 8.6% |
| 31 Dicembre 2025 | $-0.52 | $-0.48 | -9.3% | |
| 30 Settembre 2025 | $-0.47 | $-0.60 | 21.9% | |
| 30 Giugno 2025 | $-0.55 | $-0.60 | 8.0% | |
| 31 Marzo 2025 | $-0.51 | $-0.66 | 22.1% | |
| 31 Dicembre 2024 | $-0.60 | $-0.68 | 11.9% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $60M | $64M | $46M | $24M | · | |
| SG&A Expense | $24M | $25M | $21M | $9M | · | |
| Operating Expenses | $84M | $89M | $67M | $33M | $16M | |
| Operating Income | $-84M | $-89M | $-67M | $-33M | $-16M | |
| Interest Income | · | · | $7M | $2M | · | |
| Other Non-op | $-270.0K | $-558.0K | $-322.0K | $1M | $21.0K | |
| Pretax Income | $-78M | $-80M | · | · | · | |
| Income Tax | $0 | · | · | · | · | |
| Net Income | $-78M | $-81M | $-60M | $-31M | $-16M | |
| EPS (Basic) | $-2.02 | $-2.38 | $-2.74 | $-7.56 | $-9.32 | |
| EPS (Diluted) | $-2.02 | $-2.38 | $-2.74 | $-7.56 | $-9.32 | |
| Shares (Basic) | 38,509,281 | 33,791,817 | 22,078,190 | 4,121,912 | 1,743,382 | |
| Shares (Diluted) | 38,509,281 | 33,791,817 | 22,078,190 | 4,121,912 | 1,743,382 | |
| EBITDA | $-84M | $-89M | $-67M | $-33M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $40M | $36M | $30M | $100M | |
| Short-term Investments | $77M | $140M | $91M | $98M | · | |
| Prepaid Expense | $2M | $2M | $2M | $4M | $805.0K | |
| Current Assets | $120M | $182M | $130M | $132M | $100M | |
| PP&E (Net) | $5M | $4M | $3M | $2M | $290.0K | |
| PP&E (Gross) | $8M | $6M | $4M | $3M | $346.0K | |
| Accum. Depreciation | $3M | $2M | $956.0K | $420.0K | $56.0K | |
| Other Non-current Assets | $2M | $2M | $251.0K | · | · | |
| Total Assets | $130M | $197M | $138M | $181M | $107M | |
| Accounts Payable | $2M | $758.0K | $5M | $904.0K | $964.0K | |
| Current Liabilities | $16M | $17M | $13M | $7M | $3M | |
| Capital Leases | $2M | $3M | $4M | $4M | $5M | |
| Total Liabilities | $17M | $20M | $17M | $11M | $8M | |
| Common Stock | $31.0K | $31.0K | $23.0K | $22.0K | $2.0K | |
| Paid-in Capital | $387M | $373M | $238M | $227M | $1M | |
| Retained Earnings | $-275M | $-197M | $-116M | $-56M | $-25M | |
| AOCI | $111.0K | $447.0K | $-83.0K | $-95.0K | · | |
| Stockholders' Equity | $113M | $177M | $121M | $170M | $-24M | |
| Liabilities + Equity | $130M | $197M | $138M | $181M | $107M | |
| Shares Outstanding | 31,648,856 | 31,231,264 | 22,522,644 | 21,920,402 | 1,769,561 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $15M | $14M | $12M | $2M | $497.0K | |
| Operating Cash Flow | $-64M | $-66M | $-43M | $-30M | $-14M | |
| CapEx | $2M | $3M | $1M | $2M | $238.0K | |
| Investing Cash Flow | $66M | $-52M | $51M | $-142M | $-238.0K | |
| Financing Cash Flow | $-749.0K | $121M | $-2M | $102M | $112M | |
| Net Change in Cash | $2M | $4M | $7M | $-70M | $98M | |
| Free Cash Flow | $-65M | $-68M | $-44M | $-32M | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -47.8% | -48.1% | -37.8% | -21.7% | · | |
| ROE | -61.0% | -43.1% | -46.6% | -49.9% | · | |
| ROIC | -74.8% | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 7.7 | 10.6 | 9.7 | 20.3 | · | |
| Quick Ratio | 7.6 | 10.4 | 9.6 | 19.6 | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $3.56 | $5.66 | $5.38 | $7.78 | · | |
| Cash Flow / Share | $-1.65 | $-1.94 | $-1.93 | $-7.31 | · | |
| Cash / Share | $1.31 | $1.27 | $1.60 | $1.35 | · | |
| EPS (TTM) | $-2.02 | $-2.38 | $-2.74 | $-7.56 | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-78M | $-81M | $-60M | $-31M | · | |
| Market Cap | $76M | $188M | $111M | $253M | · | |
| P/E | -1.2 | -2.5 | -1.8 | -1.5 | · | |
| P/B | 0.7 | 1.1 | 0.9 | 1.5 | · | |
| P / Tangible Book | 0.7 | 1.1 | 0.9 | 1.5 | · | |
| P / Cash Flow | -1.2 | -2.9 | -2.6 | -8.4 | · | |
| P / FCF | -1.2 | -2.7 | -2.5 | -7.8 | · | |
| Earnings Yield | -83.8% | -39.5% | -55.7% | -65.6% | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $14M | $15M | $15M | $14M | $16M | $15M | $19M | $19M | $15M | $11M | $15M | $10M | $11M | $10M | · | · | |
| SG&A Expense | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | · | · | |
| Operating Expenses | $19M | $20M | $20M | $20M | $23M | $22M | $25M | $25M | $21M | $18M | $21M | $16M | $16M | $14M | $10M | $10M | |
| Operating Income | $-19M | $-20M | $-20M | $-20M | $-23M | $-22M | $-25M | $-25M | $-21M | $-18M | $-21M | $-16M | $-16M | $-14M | $-10M | $-10M | |
| Other Non-op | $-156.0K | $-129.0K | $-116.0K | $-53.0K | $-87.0K | $-14.0K | $-240.0K | $1.0K | $-55.0K | $-264.0K | $109.0K | $-97.0K | $-164.0K | $-170.0K | $1M | $377.0K | |
| Net Income | $-18M | $-19M | $-19M | $-18M | $-21M | $-20M | $-23M | $-22M | $-19M | $-16M | $-19M | $-14M | $-14M | $-13M | $-9M | $-9M | |
| EPS (Basic) | $-0.43 | $-0.49 | $-0.49 | $-0.47 | $-0.55 | $-0.51 | $-0.54 | $-0.59 | $-0.52 | $-0.73 | $-0.87 | $-0.66 | $-0.63 | $-0.58 | $4.98 | $-5.17 | |
| EPS (Diluted) | $-0.43 | $-0.49 | $-0.49 | $-0.47 | $-0.55 | $-0.51 | $-0.54 | $-0.59 | $-0.52 | $-0.73 | $-0.87 | $-0.66 | $-0.63 | $-0.58 | $4.98 | $-5.17 | |
| Shares (Basic) | 41,841,887 | 38,724,803 | · | 38,560,464 | 38,461,619 | 38,350,444 | · | 38,105,131 | 36,132,616 | 22,590,804 | · | 22,081,162 | 21,971,032 | 21,920,570 | · | 1,778,255 | |
| Shares (Diluted) | 41,841,887 | 38,724,803 | · | 38,560,464 | 38,461,619 | 38,350,444 | · | 38,105,131 | 36,132,616 | 22,590,804 | · | 22,081,162 | 21,971,032 | 21,920,570 | · | 1,778,255 | |
| EBITDA | $-19M | $-20M | · | $-20M | $-23M | $-22M | · | $-25M | $-21M | $-18M | · | $-16M | $-16M | $-14M | · | $-10M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $34M | $41M | $35M | $42M | $39M | $40M | $43M | $46M | $25M | $36M | $30M | $38M | $27M | $30M | $32M | |
| Short-term Investments | $49M | $64M | $77M | $94M | $96M | $110M | $140M | $144M | $135M | $85M | $91M | $112M | $113M | $93M | $98M | · | |
| Prepaid Expense | $2M | $1M | $2M | $1M | $989.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $4M | $2M | |
| Current Assets | $91M | $99M | $120M | $130M | $138M | $151M | $182M | $189M | $182M | $112M | $130M | $144M | $153M | $124M | $132M | $79M | |
| PP&E (Net) | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $5M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $8M | $8M | $8M | $8M | $8M | $7M | $6M | $6M | $5M | $5M | $4M | $3M | $3M | $3M | $3M | $2M | |
| Accum. Depreciation | $4M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $1M | $956.0K | $807.0K | $674.0K | $545.0K | $420.0K | $295.0K | |
| Other Non-current Assets | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | · | · | $251.0K | · | · | · | · | · | |
| Total Assets | $99M | $108M | $130M | $145M | $159M | $176M | $197M | $215M | $231M | $121M | $138M | $151M | $160M | $170M | $181M | $88M | |
| Accounts Payable | $861.0K | $1M | $2M | $996.0K | $1M | $4M | $758.0K | $2M | $1M | $2M | $5M | $2M | $1M | $1M | $904.0K | $2M | |
| Current Liabilities | $11M | $11M | $16M | $15M | $13M | $14M | $17M | $15M | $11M | $9M | $13M | $9M | $7M | $6M | $7M | $6M | |
| Capital Leases | $980.0K | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Total Liabilities | $12M | $12M | $17M | $17M | $16M | $16M | $20M | $18M | $15M | $13M | $17M | $13M | $11M | $10M | $11M | $11M | |
| Common Stock | $42.0K | $38.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $23.0K | $23.0K | $22.0K | $22.0K | $22.0K | $22.0K | $2.0K | |
| Paid-in Capital | $399M | $389M | $387M | $384M | $381M | $377M | $373M | $370M | $368M | $241M | $238M | $236M | $232M | $229M | $227M | $2M | |
| Retained Earnings | $-312M | $-294M | $-275M | $-256M | $-238M | $-217M | $-197M | $-174M | $-152M | $-133M | $-116M | $-97M | $-83M | $-69M | $-56M | $-47M | |
| AOCI | $-33.0K | $4.0K | $111.0K | $112.0K | $106.0K | $283.0K | $447.0K | $782.0K | $-19.0K | $-70.0K | $-83.0K | $-302.0K | $-427.0K | $9.0K | $-95.0K | $-133.0K | |
| Stockholders' Equity | $87M | $96M | $113M | $129M | $143M | $160M | $177M | $197M | $216M | $108M | $121M | $138M | $149M | $160M | $170M | $-46M | |
| Liabilities + Equity | $99M | $108M | $130M | $145M | $159M | $176M | $197M | $215M | $231M | $121M | $138M | $151M | $160M | $170M | $181M | $88M | |
| Shares Outstanding | 42,847,215 | 38,745,032 | 31,648,856 | 31,549,770 | 31,449,744 | 31,352,067 | 31,231,264 | 31,130,892 | 30,966,255 | 22,637,539 | 22,522,644 | 22,104,469 | 22,068,660 | 21,920,634 | 21,920,402 | 1,794,600 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $267.0K | |
| Operating Cash Flow | $-15M | $-21M | $-15M | $-12M | $-17M | $-20M | $-17M | $-17M | $-14M | $-17M | $-12M | $-10M | $-9M | $-11M | $-9M | $-7M | |
| CapEx | $87.0K | $14.0K | $219.0K | $899.0K | $493.0K | $58.0K | $827.0K | $989.0K | $137.0K | $815.0K | $1M | $0 | $112.0K | $25.0K | $251.0K | $426.0K | |
| Investing Cash Flow | $15M | $13M | $22M | $6M | $19M | $19M | $14M | $16M | $-88M | $6M | $21M | $2M | $19M | $9M | $-95M | $-45M | |
| Financing Cash Flow | $7M | $-33.0K | $-192.0K | $-117.0K | $-97.0K | $-343.0K | $-647.0K | $-2M | $123M | $-172.0K | $-2M | $78.0K | · | · | $102M | $-140.0K | |
| Net Change in Cash | $7M | $-7M | $6M | $-6M | $3M | $-664.0K | $-4M | $-3M | $21M | $-11M | $6M | $-8M | $11M | $-2M | $-3M | $-52M | |
| Free Cash Flow | · | $-21M | · | · | · | $-20M | · | · | · | $-18M | · | · | · | $-11M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -13.9% | -13.4% | · | -10.1% | -10.8% | -13.3% | · | -12.3% | -9.6% | -11.3% | · | -12.1% | -17.4% | -15.0% | · | -21.0% | |
| ROE | -15.6% | -14.9% | · | -11.2% | -11.7% | -14.7% | · | -13.4% | -10.3% | -12.3% | · | -31.3% | -18.6% | -15.9% | · | 40.3% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.0 | 9.0 | · | 8.8 | 10.3 | 11.2 | · | 12.8 | 16.2 | 12.4 | · | 15.5 | 21.8 | 21.8 | · | 12.3 | |
| Quick Ratio | 7.9 | 8.8 | · | 8.7 | 10.2 | 11.0 | · | 12.6 | 16.0 | 12.2 | · | 15.3 | 21.5 | 21.2 | · | 5.0 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.02 | $2.47 | · | $4.08 | $4.55 | $5.12 | · | $6.32 | $6.98 | $4.77 | · | $6.25 | $6.76 | $7.32 | · | $-25.42 | |
| Cash Flow / Share | · | $-0.53 | · | · | · | $-0.51 | · | · | · | $-0.76 | · | · | · | $-0.52 | · | · | |
| Cash / Share | $0.97 | $0.88 | · | $1.12 | $1.33 | $1.25 | · | $1.39 | $1.49 | $1.09 | · | $1.35 | $1.73 | $1.25 | · | $17.88 | |
| EPS (TTM) | $-1.88 | $-2.00 | · | $-2.07 | $-2.19 | $-2.16 | · | $-2.71 | $-2.78 | $-2.89 | · | $3.11 | $-1.40 | $-4.06 | · | $-15.00 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-74M | $-77M | · | $-82M | $-86M | $-84M | · | $-77M | $-69M | $-64M | · | $-50M | $-45M | $-37M | · | $-27M | |
| Market Cap | $76M | $54M | · | $57M | $37M | $64M | · | $218M | $180M | $162M | · | $211M | $286M | $278M | · | · | |
| P/E | -0.9 | -0.7 | · | -0.9 | -0.5 | -0.9 | · | -2.6 | -2.1 | -2.5 | · | 3.1 | -9.3 | -3.1 | · | · | |
| P/B | 0.9 | 0.6 | · | 0.4 | 0.3 | 0.4 | · | 1.1 | 0.8 | 1.5 | · | 1.5 | 1.9 | 1.7 | · | · | |
| P / Tangible Book | 0.9 | 0.6 | · | 0.4 | 0.3 | 0.4 | · | 1.1 | 0.8 | 1.5 | · | 1.5 | 1.9 | 1.7 | · | · | |
| P / Cash Flow | · | -2.6 | · | · | · | -3.3 | · | · | · | -9.5 | · | · | · | -24.5 | · | · | |
| Earnings Yield | -105.6% | -143.9% | · | -114.4% | -184.0% | -106.4% | · | -38.7% | -47.9% | -40.4% | · | 32.5% | -10.8% | -32.0% | · | · |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utile netto | $-78M | $-81M | $-60M | $-31M | $-16M |
| EPS Diluito | $-2.02 | $-2.38 | $-2.74 | $-7.56 | $-9.32 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 7.7 | 10.6 | 9.7 | 20.3 | · |
| Quick Ratio | 7.6 | 10.4 | 9.6 | 19.6 | · |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-65M | $-68M | $-44M | $-32M | · |
Proprietari istituzionali (13F) 48 filer · $38.1M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
48
Valore detenuto
$38.1M
Nuove posizioni
6
Posizioni chiuse
4
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 6 (-4 vs trimestre precedente) | 4 (-8 vs trimestre precedente) | 21 (+10 vs trimestre precedente) | 9 (-2 vs trimestre precedente) | +5.2M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $21.768.325 | 12.229.396 | 57,08% | Azioni |
| Sands Capital Alternatives, LLC | $4.074.902 | 2.289.271 | 10,68% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.694.574 | 952.008 | 4,44% | Azioni |
| VANGUARD GROUP INC | $1.684.246 | 698.857 | 4,42% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $1.580.871 | 888.130 | 4,15% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $1.350.776 | 758.863 | 3,54% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $1.141.866 | 641.498 | 2,99% | Azioni |
| MARSHALL WACE, LLP | $946.704 | 531.856 | 2,48% | Azioni |
| TWO SIGMA ADVISERS, LP | $804.393 | 333.773 | 2,11% | Azioni |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $674.442 | 378.900 | 1,77% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $472.273 | 265.241 | 1,24% | Azioni |
| BlackRock, Inc. | $425.620 | 239.112 | 1,12% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $327.748 | 184.128 | 0,86% | Azioni |
| XTX Topco Ltd | $317.265 | 178.239 | 0,83% | Azioni |
| JANE STREET GROUP, LLC | $132.874 | 74.648 | 0,35% | Azioni |
| NORTHERN TRUST CORP | $119.620 | 67.202 | 0,31% | Azioni |
| STATE STREET CORP | $119.518 | 67.145 | 0,31% | Azioni |
| UBS Group AG | $78.053 | 43.850 | 0,20% | Azioni |
| CITADEL ADVISORS LLC | $73.471 | 41.276 | 0,19% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $52.212 | 29.332 | 0,14% | Azioni |
| Spark Investment Management LLC | $50.374 | 28.300 | 0,13% | Azioni |
| PRELUDE CAPITAL MANAGEMENT, LLC | $42.747 | 24.015 | 0,11% | Azioni |
| BANK OF AMERICA CORP /DE/ | $29.204 | 16.407 | 0,08% | Azioni |
| Verdad Advisers, LP | $26.796 | 15.054 | 0,07% | Azioni |
| GOLDMAN SACHS GROUP INC | $26.558 | 14.920 | 0,07% | Azioni |
| Squarepoint Ops LLC | $23.690 | 13.309 | 0,06% | Azioni |
| AAF Wealth Management, LLC | $19.007 | 10.678 | 0,05% | Azioni |
| Marex Group Ltd | $17.800 | 10.000 | 0,05% | Azioni |
| FEDERATED HERMES, INC. | $14.105 | 7.924 | 0,04% | Azioni |
| BARCLAYS PLC | $13.090 | 7.354 | 0,03% | Azioni |
| FMR LLC | $12.383 | 6.957 | 0,03% | Azioni |
| MORGAN STANLEY | $9.315 | 5.233 | 0,02% | Azioni |
| Tower Research Capital LLC (TRC) | $2.985 | 1.677 | 0,01% | Azioni |
| ACADIAN ASSET MANAGEMENT LLC | $2.073 | 1.165.119 | 0,01% | Azioni |
| Crews Bank & Trust | $1.858 | 1.044 | 0,00% | Azioni |
| JPMORGAN CHASE & CO | $1.337 | 751 | 0,00% | Azioni |
| NISA INVESTMENT ADVISORS, LLC | $1.040 | 584 | 0,00% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $956 | 537 | 0,00% | Azioni |
| Redwood Park Advisors LLC | $890 | 500 | 0,00% | Azioni |
| Russell Investments Group, Ltd. | $856 | 481 | 0,00% | Azioni |
| Federation des caisses Desjardins du Quebec | $712 | 400 | 0,00% | Azioni |
| Steward Partners Investment Advisory, LLC | $580 | 326 | 0,00% | Azioni |
| GSA CAPITAL PARTNERS LLP | $357 | 200.415 | 0,00% | Azioni |
| SBI Securities Co., Ltd. | $134 | 75 | 0,00% | Azioni |
| Caitong International Asset Management Co., Ltd | $89 | 50 | 0,00% | Azioni |
| HRT FINANCIAL LP | $18 | 10.316 | 0,00% | Azioni |
| CITIGROUP INC | $11 | 6 | 0,00% | Azioni |
| ROYAL BANK OF CANADA | $0 | 30 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 1 partecipazione
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 depositi | 23 Aprile 2026 | 28,80% | Modifica | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 18 insider · 10 dirigenti · 8 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Peter Blume-Jensen | President and CEO | 14 Agosto 2024 F | 2.502.129 | 0 | 0 | $0 |
| Rasmus Holm-Jorgensen | Chief Financial Officer | 01 Marzo 2025 A | 26.088 | 0 | 0 | $0 |
| Eric Devroe | Chief Operating Officer | 18 Agosto 2026 S | 146.349 | 1 | 1 | $15.986 |
| Michaela Levin | Chief Business Officer | 31 Agosto 2026 A | 30.000 | 0 | 0 | $0 |
| Katharine Peterson | Chief Accounting Officer | 18 Agosto 2026 S | 18.033 | 0 | 1 | $-203 |
| Erick Gamelin | Chief Development Officer | 18 Agosto 2026 S | 52.592 | 0 | 1 | $-804 |
| Mary Miller | Chief Legal Officer | 18 Agosto 2026 S | 82.009 | 0 | 2 | $-1.380 |
| Mansoor Raza Mirza | Chief Medical Officer | 18 Maggio 2026 A | 38.817 | 0 | 0 | $0 |
| Jean-Marie Cuillerot | Chief Medical Officer | 01 Marzo 2025 A | · | 0 | 0 | $0 |
| Kristina Masson | EVP - Business Operations | 14 Agosto 2024 F | 317.246 | 0 | 0 | $0 |
| Santhosh Palani | Direttore | 17 Giugno 2026 A | 9.366 | 0 | 0 | $0 |
| Derek Dirocco | Direttore | 17 Giugno 2026 A | 9.366 | 0 | 0 | $0 |
| Sharon Shacham | Direttore | 17 Giugno 2026 A | 9.366 | 0 | 0 | $0 |
| Charles M Baum | Direttore | 17 Giugno 2026 A | 9.366 | 0 | 0 | $0 |
| Michael John Tomsicek | Direttore | 17 Giugno 2026 A | 9.366 | 0 | 0 | $0 |
| Ivana Magovcevic-Liebisch | Direttore | 17 Giugno 2026 A | 9.366 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Proprietario del 10% | 17 Novembre 2022 C | 888.130 | 0 | 0 | $0 |
| Adam D. Levy | · | 04 Agosto 2026 S | 66.008 | 1 | 1 | $13.221 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 3 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
ACRV Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 13 analisti
COMPRA
Target mediano
$10.50
+427,6%
4 30,8%
Acquisto forte
8 61,5%
Compra
1 7,7%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
6 analisti · 2026-10-03Target medio $11.50 +477,9%
← Sotto tutti i target
Prezzo attuale $1.99
Basso$7.00
Media$11.50
Alto$19.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| ACRV | $76M | -1.2 | · | · | -61.0% | · |
| CTOR | $170M | -6.0 | · | · | -61.5% | · |
| CNXU | · | · | · | · | · | · |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | · |
| MNOV | $64M | -5.5 | · | -2928.8% | -27.1% | · |
| ICCC | · | -51.2 | 4.3% | · | · | · |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | · |
| SERA | · | -4.4 | 5.2% | -39417.3% | -39.0% | · |
| GRML | · | · | · | · | -104.9% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 12, 2026